Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation
- PMID: 30808223
- PMCID: PMC6714949
- DOI: 10.1177/1076029618824044
Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation
Abstract
The primary end point for sepsis trial is 28-day mortality. However, additional methods for determining the efficacy may have benefits. The purpose of this study was to search a useful indicator of anticoagulant therapy in patients with sepsis with disseminated intravascular coagulation (DIC). Data from 323 patients with sepsis with coagulopathy treated with antithrombin supplementation were analyzed. The changes in the Sequential Organ Failure Assessment (Δ SOFA) score, the overt-DIC (Δ overt-DIC) score, and the Japanese Society for Acute Medicine DIC (Δ JAAM DIC) score from baseline to day 7 were retrospectively analyzed in relation to the 28-day mortality. Significant correlations were found between the 28-day mortality and Δ SOFA, Δ overt-DIC score, and Δ JAAM DIC score. The accuracy of the prediction was higher for Δ SOFA (80.5%) than for Δ overt-DIC (66.7%, P < .001). The areas under the curve for mortality calculated using a receiver operating characteristic curve analysis were 0.812 for Δ SOFA, 0.655 for Δ overt-DIC, and 0.693 for Δ JAAM DIC. The mortality rate was significantly lower among cases with an improved SOFA score compared to those without an improvement. The Δ SOFA had the strongest association with the 28-day mortality in patients with sepsis and DIC.
Keywords: antithrombin; clinical practice; disseminated intravascular coagulation; sepsis; sequential organ failure assessment score.
Conflict of interest statement
Figures

Similar articles
-
Risk stratification utilizing sequential organ failure assessment (SOFA) score, antithrombin activity, and demographic data in sepsis-associated disseminated intravascular coagulation (DIC).Sci Rep. 2023 Dec 15;13(1):22502. doi: 10.1038/s41598-023-49855-y. Sci Rep. 2023. PMID: 38110515 Free PMC article.
-
Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.Thromb Haemost. 2008 Dec;100(6):1099-105. Thromb Haemost. 2008. PMID: 19132236
-
Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation.Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):145S-149S. doi: 10.1177/1076029618797474. Epub 2018 Sep 9. Clin Appl Thromb Hemost. 2018. PMID: 30198317 Free PMC article. Clinical Trial.
-
Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy.Acute Med Surg. 2019 Apr 1;6(3):223-232. doi: 10.1002/ams2.411. eCollection 2019 Jul. Acute Med Surg. 2019. PMID: 31304023 Free PMC article. Review.
-
A comparison of disseminated intravascular coagulation scoring systems and their performance to predict mortality in sepsis patients: A systematic review and meta-analysis.PLoS One. 2025 Jan 16;20(1):e0315797. doi: 10.1371/journal.pone.0315797. eCollection 2025. PLoS One. 2025. PMID: 39821194 Free PMC article.
Cited by
-
Performances of disseminated intravascular coagulation scoring systems in septic shock patients.Ann Intensive Care. 2020 Jul 10;10(1):92. doi: 10.1186/s13613-020-00704-5. Ann Intensive Care. 2020. PMID: 32651674 Free PMC article.
-
Prognostic value of PaO2/FiO2, SOFA and D-dimer in elderly patients with sepsis.J Int Med Res. 2022 Jun;50(6):3000605221100755. doi: 10.1177/03000605221100755. J Int Med Res. 2022. PMID: 35751423 Free PMC article.
-
Predicting organ functioning with and without blood transfusion in critically ill patients with anemia.Transfusion. 2022 Aug;62(8):1527-1536. doi: 10.1111/trf.16998. Epub 2022 Jun 30. Transfusion. 2022. PMID: 35770740 Free PMC article.
-
Determining prognostic indicator for anticoagulant therapy in sepsis-induced disseminated intravascular coagulation.J Intensive Care. 2024 Jun 24;12(1):24. doi: 10.1186/s40560-024-00739-x. J Intensive Care. 2024. PMID: 38915122 Free PMC article.
-
Recent advances in the research and management of sepsis-associated DIC.Int J Hematol. 2021 Jan;113(1):24-33. doi: 10.1007/s12185-020-03053-y. Epub 2021 Jan 2. Int J Hematol. 2021. PMID: 33386597 Free PMC article. Review.
References
-
- Levi M, Schultz M, van der Poll T. Sepsis and thrombosis. Semin Thromb Hemost. 2013;39(5):559–566. - PubMed
-
- Semeraro N, Ammollo CT, Semeraro F, et al. Sepsis, thrombosis and organ dysfunction. Thromb Res. 2012;129(3):290–295. - PubMed
-
- Kidokoro A, Iba T, Fukunaga M, et al. Alterations in coagulation and fibrinolysis during sepsis. Shock. 1996;5(3):223–228. - PubMed
-
- Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost. 2017;16(2):231–241. - PubMed
-
- Ogura H, Gando S, Saitoh G, et al. Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study. J Infect Chemother. 2014;20(3):157–162. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical